Archive for December, 2006

The Epidemic called OBESITY

Wednesday, December 27th, 2006

Obesity has become a global pandemic affecting the lives and health of millions of people, according to the World Health Organization. It is an accelerating social problem in industrialized countries and is also growing in the former colonial world. 
Obesity is very often defined as an eating disorder. However, it is not a simple condition of eating too much.  Health experts believe that obesity is a serious and chronic disease prevalent in today’s society.

As the “obesity epidemic” increases, so is the number of people that suffers from it. Approximately 300,000 adult deaths in the United States alone each year are directly attributable to unhealthy dietary habits and physical inactivity or sedentary behavior or obesity.   In the United States alone, nearly one third of the adult population is obese.  In the Europe, they have a similar encounter of the disease.  An astonishing 58 per cent of Britain’s adult population is considered overweight or obese, a report published in England said.  The National Audit Office of Britain reported last year that 20 percent of British women and 17 percent of men were as much as 70 pounds heavier than the recommended weight for their size. 

Obesity is not just a health issue.  It is also considered as a socio-economic problem that utilizes $117 billion per year in the United States alone.  In Britain, obesity cost £2.6 billion in NHS bills and indirect losses to the UK economy.  At least 18 million sick days a year can be attributed to obesity, it says, and the increased risk of heart disease, diabetes, colon cancer and stroke reduces life expectancy by around nine years.

When it comes to explaining these trends, not only media reports, but many scientific articles disparagingly refer to a combination of fast food, increasing car ownership and a sedentary lifestyle in front of television sets or computer monitors.

In the first place, such generalisations are often backed by little substantiated data. Some studies have found that the prevalence of obesity among children is directly related to the hours of television viewed, for example, but other studies have failed to establish a correlation.

More fundamentally, these observations ignore the economic and social driving forces behind the changes in diet and lifestyle—including the profits generated by the food and entertainment industries—and the intense pressures caused by increasing working hours and declining living standards for the majority of working people.

Obesity can also lower the life expectancy of individuals.  In addition to this, obese people are increasing their susceptibility and risks to a number of diseases directly related to obesity.  This includes:  type 2 (adult onset) diabetes; high blood pressure; stroke; heart attack; heart failure;  cancer such as cancer of the colon or rectum; gallstones; gout and gouty arthritis; osteoarthritis; sleep apnea; and pickwickian syndrome.

New clinically proven medical weight loss device



New product Proactol shown to bind up to 28% of dietary fat intake
4 published clinical studies have shown the new medical device Proactol was able to regulate blood lipid levels and thus participate in reducing cardiovascular risk. The studies showed that Proactol was able to bind over 27% of dietary fat intake, reduce calorie intake from dietary fats, help reduce excess body weight, suppress appetite, reduce blood cholesterol levels and reduce food cravings among the test subjects in the clinical studies.



Proactol is a patented fibre complex that is a 100% natural, 100% organic fat binder made from dehydrated leaves of the nutritious cactus "Opuntia ficus-indica".

This natural fibre complex consists of two fibers; a non-soluble fibre and a soluble fibre that both work in different ways to help you manage your weight.

The studies showed that when Proactol non-soluble fibres come into contact with dietary fats, it binds with them immediately to form a fluid gel around the fat making it insoluble. Unabsorbed fats then pass naturally through your body. The clinical studies showed Proactol will bind up to 28% of dietary fats

This fat binding property of Proactol enabled the test subjects to eat normally and still lose weight.

The studies also showed that Proactol soluble fibers are highly viscous when they bind with bile acids to create a very viscous solution, which slows down digestion and slows down the absorption of glucose.

This helped to suppress appetite and food cravings amongst the test subjects.



As a result of these clinical studies Proactol has been certified as medical product (MDD 93/42/EEC) for the treatment of obesity and weight management. For more information on this product please visit Proactol's website.


Other Weight Loss Resources

eXTReMe Tracker